TY - JOUR
T1 - Whole-Virus Screening to Develop Synbodies for the Influenza Virus
AU - Gupta, Nidhi
AU - Lainson, John
AU - Domenyuk, Valeriy
AU - Zhao, Zhan-Gong
AU - Johnston, Stephen
AU - Diehnelt, Chris
N1 - Publisher Copyright:
© 2016 American Chemical Society.
PY - 2016/10/19
Y1 - 2016/10/19
N2 - There is an ongoing need for affinity agents for emerging viruses and new strains of current human viruses. We therefore developed a robust and modular system for engineering high-affinity synbody ligands for the influenza A/Puerto Rico/8/1934 H1N1 virus as a model system. Whole-virus screening against a peptide microarray was used to identify binding peptides. Candidate peptides were linked to bis-maleimide peptide scaffolds to produce a library of candidate influenza-binding synbodies. From this library, a candidate synbody, ASU1060, was selected and affinity-improved via positional substitution using d-amino acids to produce a new synbody, ASU1061, that bound H1N1 in an ELISA assay with a KD of <1 nM, comparable to that of a monoclonal antibody for neuraminidase (NA). We prepared a modified version of ASU1061 that contained an additional C-terminal peptide to simulate conjugation of the synbody to a carrier protein, called ASU1063, and found that H1N1 binding was unchanged. Subsequent work identified the synbody target as nucleoprotein (NP), a highly conserved protein in influenza, with a KD of <1 nM for ASU1063. This suggests that virus-binding synbodies can be conjugated to carrier proteins or other moieties that could improve the therapeutic profile of the resulting synbody. This method is a rapid process that offers a means of developing new affinity ligands to influenza and other viruses.
AB - There is an ongoing need for affinity agents for emerging viruses and new strains of current human viruses. We therefore developed a robust and modular system for engineering high-affinity synbody ligands for the influenza A/Puerto Rico/8/1934 H1N1 virus as a model system. Whole-virus screening against a peptide microarray was used to identify binding peptides. Candidate peptides were linked to bis-maleimide peptide scaffolds to produce a library of candidate influenza-binding synbodies. From this library, a candidate synbody, ASU1060, was selected and affinity-improved via positional substitution using d-amino acids to produce a new synbody, ASU1061, that bound H1N1 in an ELISA assay with a KD of <1 nM, comparable to that of a monoclonal antibody for neuraminidase (NA). We prepared a modified version of ASU1061 that contained an additional C-terminal peptide to simulate conjugation of the synbody to a carrier protein, called ASU1063, and found that H1N1 binding was unchanged. Subsequent work identified the synbody target as nucleoprotein (NP), a highly conserved protein in influenza, with a KD of <1 nM for ASU1063. This suggests that virus-binding synbodies can be conjugated to carrier proteins or other moieties that could improve the therapeutic profile of the resulting synbody. This method is a rapid process that offers a means of developing new affinity ligands to influenza and other viruses.
UR - http://www.scopus.com/inward/record.url?scp=84992406252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992406252&partnerID=8YFLogxK
U2 - 10.1021/acs.bioconjchem.6b00447
DO - 10.1021/acs.bioconjchem.6b00447
M3 - Article
C2 - 27658460
AN - SCOPUS:84992406252
SN - 1043-1802
VL - 27
SP - 2505
EP - 2512
JO - Bioconjugate chemistry
JF - Bioconjugate chemistry
IS - 10
ER -